Piscataway, NJ (PressExposure) November 07, 2012 -- CelKine is a dedicated sub-brand of GenScript USA relating cytokine business and products. CelKine's website, (www.celkine.com), has been officially launched today. Customers can now order cytokine products online quickly and easily.
CelKine supplies a comprehensive spectrum of cytokines and growth factors with high bioactivity. Compared with the cytokine products available on the market, Celkine products from GenScript have extremely low endotoxin levels and can be used not only for general research, but also for primary cell cultures and stem cell studies. Cytokines and growth factors from CelKine are produced according to stringent GLP guidelines, ensuring the lowest possible levels of endotoxin contamination. Functional bioactivity is tested through Genscript's internal bioassay department as well as through a professional third party, reducing negative risks and guaranteeing a high quality product.
After optimization, Celkine's website will allow customers to quickly find cytokine products with a convenient search function and finish the online order process easily. Additionally, customers with a previous account with GenScript do not need to register again. A quick-order function can be used to repurchase a previous order. Using the newly integrated custom ordering system, customers also have options for more flexible choices to acquire the proteins they need.
CelKine's website also allows customers to have access to the latest stem cell news and will feature recently published academic papers about stem cell research. CelKine aims to be a reliable supplier and an excellent resource for stem cell researchers to achieve their goals more rapidly.
GenScript's Celkine brand will include a comprehensive spectrum of cytokine proteins, growth factors, chemokines, and other related proteins and antibodies.
Therefore, besides general use, they are particularly suitable for researches that require high quality cytokines such as primary cell culture or stem cell studies.
# # # #
For further information, please contact:
Executive Vice President
GENSCRIPT USA Inc.